Answers are grounded in this paper and cite their sources.
B. thetaiotaomicron displays strong efficacy in preclinical models of IBD and protects against weight loss, histopathological changes in the colon and inflammatory markers. These data indicate that the live strain or its products may be a novel alternative to current treatment options for Crohn's disease.
No takes yet. Share an insight, caveat, or question.
Delday et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: